SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?


To: Greg Rich who wrote (1105)12/2/1999 12:50:00 PM
From: tuck  Respond to of 2515
 
Greg,

Certainly IMCL has treated me well, though I have no position now. Got called out again. Almost all is well in my trading universe, except a few parsecs away in ESTI. Could be the makings of a lawsuit there. Thank goodness for diversification and hedging!

Methinks IMCL is looking a bit toppy, short term. Just my HO and I'm not making any bets one way or the other.

Cheers, Tuck



To: Greg Rich who wrote (1105)12/7/1999 9:17:00 AM
From: WTSherman  Read Replies (1) | Respond to of 2515
 
This is pretty big news. C225 moving into PII trials for pancreatic cancer after very positive pre-clinical results. This is just about the most difficult to treat cancer there is. A breakthrough here will be an amazing thing for victims of this form of cancer and for the company...

biz.yahoo.com